Peppermint Oil Pharmacokinetics/Dynamics

Status Withdrawn

Clinical Trial Summary

In children 7-12 years of age with functional abdominal pain (n=42) determine: Aim 1 - To examine and characterize the threshold of the exposure (PK) vs. response (PD) relationship of PMO (menthol) Aim 2 - PD of PMO as assessed by: 1. Microbiome composition (16S RNA sequencing) 2. Transit rate/contractile activity (using the SmartPill®) Aim 3 - Evaluate the potential association between PD response and clinical symptoms (abdominal pain and stooling pattern via validated diary), psychosocial distress (anxiety, depression, somatization), and characterize potential side effects (questionnaire)

Clinical Trial Description

An initial single-dose PK study will be carried out. Forty-two children (n=21 per dose) will be randomized to receive approximately 10.9 mg·kg-1·d-1 of PMO or to receive approximately 18.2 mg·kg-1·d-1 (1.67-fold the median dose). Following the single-dose PK study, a PD study will be carried out wherein the subjects will receive their assigned dose of PMO for 7 days. At baseline (before the PK study) and after the PK study (i.e., during the PD study), subjects will keep a pain and stooling diary, collect stool for microbiome analysis, and swallow a SmartPill to measure gut motility and transit time. At baseline only, anxiety, depression, somatization will be measured. During the PD study, any side effects will be recorded. ;

Study Design

Related Conditions & MeSH terms

Abdominal Pain

Clinical Trial Details

NCT number	NCT04497870
Study type	Interventional
Source	Baylor College of Medicine
Contact
Status	Withdrawn
Phase	Phase 1
Start date	July 9, 2020
Completion date	September 14, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04682860` - Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide	Phase 4
Not yet recruiting	`NCT05649891` - Checklists Resuscitation Emergency Department	N/A
Completed	`NCT02923245` - POCUS Assessment of Bladder Fullness for Girls Awaiting Radiology-Performed Transabdominal Pelvic Ultrasound	N/A
Completed	`NCT03318614` - Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster	Phase 2/Phase 3
Completed	`NCT02547857` - Transvaginal Pelvic Ultrasound in the ED	N/A
Completed	`NCT02197780` - Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD	N/A
Completed	`NCT02676232` - DARWeb: an Online Psychosocial Intervention for Children With Recurrent Abdominal Pain and Their Families.	N/A
Recruiting	`NCT00209807` - Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder	Phase 4
Terminated	`NCT01410071` - Evaluation of Gastrointestinal Symptoms and Quality of Life in Patients With Sphincter of Oddi Dysfunction	N/A
Terminated	`NCT01736280` - Evaluating and Treating Potential Research Participants With Digestive Disorders	N/A
Enrolling by invitation	`NCT04104867` - Effectiveness of Prokinetic Agents in Improving Abdominal Discomfort at Colonoscopy	N/A
Completed	`NCT03574727` - Abdominal Cutaneous Nerve Entrapment Syndrome
Completed	`NCT04614649` - Right Iliac Fossa Treatment-Turkey Audit
Completed	`NCT05438654` - Improvement of Diagnostic Approach Using PoCUS for Right Upper Quadrant Abdominal Pain	N/A
Completed	`NCT06423586` - Effect of Lecithin-based Curcuma and Boswellia on Post-acute COVID-19 IBS	N/A
Completed	`NCT03558009` - Epidemiological Analysis for Hereditary Angioedema Disease
Terminated	`NCT03148288` - Vitamin D Supplementation in IBS	N/A
Completed	`NCT03708874` - Pain Management of Emergency Laparoscopic Cholecystectomy in Patients With Acute Cholecystitis
Withdrawn	`NCT04408872` - EUS vs EGD in Emergency Room Patients Referred for EGD	N/A
Recruiting	`NCT02594774` - Efficacy of Osteopathic Treatment in Function Abdominal Pain in Children and Adolescents	N/A